EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: Short report

Clinical and Experimental Metastasis

Volumn 30, Issue 8, 2013, Pages 1063-1071

  Kamila, Wojas Krawczyk ^a   Michał, Skroński ^b   Paweł, Krawczyk ^a   Paulina, Jaguå ^b   Tomasz, Kucharczyk ^a,c   Bozena, Jarosz ^a   Radosław, Mlak ^a   Justyna, Szumiło ^a   Marek, Sawicki ^a   Trojanowski, Tomasz ^a   Janusz, Milanowski ^a,d   Joanna, Chorostowska Wynimko ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^c MEDICAL UNIVERSITY OF WARSAW   (Poland)

^d INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

Allele specific primer PCR; Central nervous system metastases; EGFR mutations; NSCLC; Peptide nucleic acid locked nucleic acid PCR clamp

Indexed keywords

DNA FRAGMENT; EPIDERMAL GROWTH FACTOR RECEPTOR; FORMALDEHYDE; LOCKED NUCLEIC ACID; PARAFFIN; PEPTIDE NUCLEIC ACID;

ADULT; ALLELE SPECIFIC PRIMER POLYMERASE CHAIN REACTION; AMINO ACID SUBSTITUTION; ARTICLE; CAUCASIAN; CENTRAL NERVOUS SYSTEM METASTASIS; CONTROLLED STUDY; DNA FRAGMENT LENGTH ANALYSIS; EXON; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PEPTIDE NUCLEIC ACID LOCKED NUCLEIC ACID POLYMERASE CHAIN REACTION; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIMARY TUMOR; SENSITIVITY ANALYSIS; SMOKING;

ADENOCARCINOMA; AGED; BRAIN NEOPLASMS; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK FACTORS;

EID: 84890442638     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9603-8     Document Type: Article

References (29)

1. Tanaka T, Matsuoka M, Sutani A, Gemma A, Maemondo M, Inoue A, Okinaga S, Nagashima M, Oizumi S, Uematsu K, Nagai Y, Moriyama G, Miyazawa H, Ikebuchi K, Morita S, Kobayashi K, Hagiwara K (2010) Frequency of and variables associated with the EGFR mutation and its subtypes. Int J Cancer 126(3):651-655
2. Angulo B, Conde E, Suárez-Gauthier A, Plaza C, Martínez R, Redondo P, Izquierdo E, Rubio-Viqueira B, Paz-Ares L, Hidalgo M, López-Ríos F (2012) A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry. PLoS One 7(8):e43842
3. Kamel-Reid S, Chong G, Ionescu DN, Magliocco AM, Spatz A, Tsao M, Weng X, Young S, Zhang T, Soulieres D (2012) EGFR tyrosine kinase mutation testing in the treatment of non-small-cell lung cancer. Curr Oncol 19(2):e67-e74
4. Marchetti A, Normanno N, Pinto C, Taddei GL, Adamo V, Ardizzoni A, Botti G, Bardelli A, Comin C, Crinò L, Fontanini G, Gambacorta M, Marchetti A, Murer B, Normanno N, Nappi O (2010) Recommendations for mutational analysis of EGFR in lung carcinoma. Pathologica 102:22-119
5. Molina-Vila MA, Bertran-Alamillo J, Reguart N, Taron M, Castellà E, Llatjós M, Costa C, Mayo C, Pradas A, Queralt C (2008) A sensitive method for detecting EGFR mutations in non-small cell lung cancer samples with few tumor cells. J Thorac Oncol 3(11):1224-1235
6. Nakamura T, Sueoka-Aragane N, Iwanaga K, Sato A, Komiya K, Kobayashi N, Hayashi S, Hosomi T, Hirai M, Sueoka E, Kimura S (2012) Application of highly sensitive detection system for epidermal growth factor receptor mutations in plasma DNA. J Thorac Oncol 7(9):1369-1381
7. Pareek CS, Smoczyński R, Tretyn A (2011) Sequencing technologies and genome sequencing. J Appl Genet 52:413-435
8. Pan Q, Pao W, Ladanyi M (2005) Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas. J Mol Diagn 7(3):396-403
9. Nagai Y, Miyazawa H, Huqun, Tanaka T, Udagawa K, Kato M, Fukuyama S, Yokote A, Kobayashi K, Kanazawa M, Hagiwara K (2005) Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res 65(16):7276-7282
10. Le Maignan L, Mirebeau-Prunier D, Vervueren L, Jeanfaivre T, Urban T, Hureaux J (2011) First case of A859T epidermal growth factor receptor mutation responding to erlotinib. J Thorac Oncol 6(3):639-640
11. Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48-54
12. Porta R, Sánchez-Torres JM, Paz-Ares L, Massutí B, Reguart N, Mayo C, Lianes P, Queralt C, Guillem V, Salinas P, Catot S, Isla D, Pradas A, Gúrpide A, de Castro J, Polo E, Puig T, Tarón M, Colomer R, Rosell R (2011) Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation. Eur Respir J 37(3):624-631
13. Jamal-Hanjani M, Spicer J (2012) Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of epidermal growth factor receptor-mutant non-small cell lung cancer metastatic to the brain. Clin Cancer Res 18(4):938-944
14. Matsumoto S, Takahashi K, Iwakawa R, Matsuno Y, Nakanishi Y, Kohno T, Shimizu E, Yokota J (2006) Frequent EGFR mutations in brain metastases of lung adenocarcinoma. Int J Cancer 119(6):1491-1494
15. Han HS, Eom DW, Kim JH, Kim KH, Shin HM, An JY, Lee KM, Choe KH, Lee KH, Kim ST, Koo JH, Lee HC, Lee OJ (2011) EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases. Clin Lung Cancer 12(6):380-386
16. Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, Majem M, Lopez-Vivanco G, Isla D, Provencio M, Insa A, Massuti B, Gonzalez-Larriba JL, Paz-Ares L, Bover I, Garcia-Campelo R, Moreno MA, Catot S, Rolfo C, Reguart N, Palmero R, Sánchez JM, Bastus R, Mayo C, Bertran-Alamillo J, Molina MA, Sanchez JJ, Taron M, Spanish Lung Cancer Group (2009) Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 361(10):958-967
17. Munfus-McCray D, Harada S, Adams C, Askin F, Clark D, Gabrielson E, Li QK (2011) EGFR and KRAS mutations in metastatic lung adenocarcinomas. Hum Pathol 42(10):1447-1453
18. Grommes C, Oxnard GR, Kris MG, Miller VA, Pao W, Holodny AI, Clarke JL, Lassman AB (2011) "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer. Neuro Oncol 13(12):1364-1369
19. Krawczyk P, Ramlau R, Powrózek T, Wojas-Krawczyk K, Sura S, Jarosz B, Walczyna B, Pankowski J, Szumiło J, Dyszkiewicz W, WoÅniak A, Milanowski J (2012) The detection of EGFR mutations in patients with non- small cell lung cancer in selected center in Poland involved in the molecular diagnostics. Kardiochirurgia i Torakochirurgia Polska 9(4):431-438
20. Petrelli F, Borgonovo K, Cabiddu M, Barni S (2012) Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small-cell lung cancer: a meta-analysis of 13 randomized trials. Clin Lung Cancer 13(2):107-114
21. Togashi Y, Masago K, Kubo T, Sakamori Y, Kim YH, Hatachi Y, Fukuhara A, Mio T, Togashi K, Mishima M (2011) Association of diffuse, random pulmonary metastases, including miliary metastases, with epidermal growth factor receptor mutations in lung adenocarcinoma. Cancer 117:819-825
22. Sun L, Zhang Q, Luan H (2011) Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice. J Exp Clin Cancer Res 30:30-38
23. van Eijk R, Licht J, Schrumpf M, Talebian Yazdi M, Ruano D, Forte GI, Nederlof PM, Veselic M, Rabe KF, Annema JT, Smit V, Morreau H, van Wezel T (2011) Rapid KRAS, EGFR, BRAF and PIK3CA mutation analysis of fine needle aspirates from non-small-cell lung cancer using allele-specific qPCR. PLoS ONE 6(3):e17791
24. Yamada N, Oizumi S, Asahina H, Shinagawa N, Kikuchi E, Kikuchi J, Sakakibara-Konishi J, Tanaka T, Kobayashi K, Hagiwara K, Nishimura M (2012) The peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations in bronchoscopic cytological specimens of non-small cell lung cancer. Oncol 82(6):341-346
25. Lopez-Rios F, Angulo B, Gomez B, Mair D, Martinez R, Conde E, Shieh F, Tsai J, Current R, Lawrence HJ, Gonzales de Castro D (2012) Comparison of molecular testing methods for the detection of EGFR mutations in formalin-fixed paraffin-embedded tissue (FFPET) specimens of non-small cell lung cancer (NSCLC). European Lung Cancer Conference Geneva, abs. 270
26. Ikeda T, Nakamura Y, Yamaguchi H, Tomonaga N, Doi S, Nakatomi K, Iida T, Motoshima K, Mizoguchi K, Nagayasu T, Tsukamoto K, Kohno S (2012) Direct comparison of 3 PCR methods in detecting EGFR mutations in patients with advanced non-small-cell lung cancer. Clin Lung Cancer 13(5):369-374
27. Asano H, Toyooka S, Tokumo M, Ichimura K, Aoe K, Ito S, Tsukuda K, Ouchida M, Aoe M, Katayama H, Hiraki A, Sugi K, Kiura K, Date H, Shimizu N (2006) Detection of EGFR gene mutation in lung cancer by mutant-enriched polymerase chain reaction assay. Clin Cancer Res 12(1):43-48
28. Dahse R, Berndt A, Kosmehl H (2006) PCR-based testing for therapy-related EGFR mutations in patients with non-small cell lung cancer. Anticancer Res 28:2265-2270
29. Kim HJ, Lee KY, Kim YC, Kim KS, Lee SY, Jang TW, Lee MK, Shin KC, Lee GH, Lee JC, Lee JE, Kim SY (2012) Detection and comparison of peptide nucleic acid-mediated real-time polymerase chain reaction clamping and direct gene sequencing for epidermal growth factor receptor mutations in patients with non-small cell lung cancer. Lung Cancer 75(3):321-325